Variation in the management of deep vein thrombosis: implications for the potential impact of a critical pathway.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 8629672)

Published in Am J Med on March 01, 1996

Authors

R A Schoenenberger1, S D Pearson, S Z Goldhaber, T H Lee

Author Affiliations

1: Section for Clinical Epidemiology, Harvard Community Health Plan, Brigham and Women's Hospital, Boston, Massachusetts, USA.

Articles by these authors

(truncated to the top 100)

Does housestaff discontinuity of care increase the risk for preventable adverse events? Ann Intern Med (1994) 10.29

Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials. Eur Heart J (1985) 9.28

Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III. Science (1985) 8.53

Cyclin activation of p34cdc2. Cell (1990) 6.87

An overview of randomized trials of rehabilitation with exercise after myocardial infarction. Circulation (1989) 6.87

Contaminant blood cultures and resource utilization. The true consequences of false-positive results. JAMA (1991) 6.28

RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell (1995) 5.73

The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions. J Virol (1992) 5.30

Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med (1993) 5.19

Physician reporting compared with medical-record review to identify adverse medical events. Ann Intern Med (1993) 4.60

Mutations in the N-terminal region of human immunodeficiency virus type 1 matrix protein block intracellular transport of the Gag precursor. J Virol (1993) 4.20

Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Engl J Med (1985) 4.00

Virus envelope protein of HTLV-III represents major target antigen for antibodies in AIDS patients. Science (1985) 3.81

Randomized trial of a depression management program in high utilizers of medical care. Arch Fam Med (2000) 3.68

Assessment of operative risk in patients undergoing lung resection. Importance of predicted pulmonary function. Chest (1994) 3.31

Predicting bacteremia in hospitalized patients. A prospectively validated model. Ann Intern Med (1990) 3.31

A new HTLV-III/LAV protein encoded by a gene found in cytopathic retroviruses. Science (1986) 3.20

Antigens encoded by the 3'-terminal region of human T-cell leukemia virus: evidence for a functional gene. Science (1984) 3.20

Ventricular dysfunction and the risk of stroke after myocardial infarction. N Engl J Med (1997) 3.13

Intraarterial thrombolysis of lower extremity occlusions: prospective, randomized comparison of forced periodic infusion and conventional slow continuous infusion. Radiology (1993) 3.07

Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. J Biol Chem (1991) 3.06

A new HTLV-III/LAV encoded antigen detected by antibodies from AIDS patients. Science (1985) 3.05

Critical pathways as a strategy for improving care: problems and potential. Ann Intern Med (1995) 3.03

Rapid classification of positive blood cultures. Prospective validation of a multivariate algorithm. JAMA (1992) 3.02

Effect of race on the presentation and management of patients with acute chest pain. Ann Intern Med (1993) 3.00

Generation and characterization of monoclonal antibodies to the putative CD4-binding domain of human immunodeficiency virus type 1 gp120. J Virol (1989) 3.00

Alveolar-arterial oxygen gradient in the assessment of acute pulmonary embolism. Chest (1995) 2.95

Regular inhaled salbutamol and asthma control: the TRUST randomised trial. Therapy Working Group of the National Asthma Task Force and the MRC General Practice Research Framework. Lancet (2000) 2.87

Heterogeneity of therapeutic responses in asthma. Br Med Bull (2000) 2.86

The case for case-mix adjustment in practice profiling. When good apples look bad. JAMA (1994) 2.80

Mutations in the cytoplasmic domain of human immunodeficiency virus type 1 transmembrane protein impair the incorporation of Env proteins into mature virions. J Virol (1993) 2.80

HIV-1 Langerhans' cell tropism associated with heterosexual transmission of HIV. Science (1996) 2.79

Human immunodeficiency virus vpr gene encodes a virion-associated protein. AIDS Res Hum Retroviruses (1990) 2.67

Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. Ann Intern Med (1992) 2.63

Open reading frame vpr of simian immunodeficiency virus encodes a virion-associated protein. J Virol (1990) 2.60

Endothelial leukocyte adhesion molecule-1 and intercellular adhesion molecule-1 mediate the adhesion of eosinophils to endothelial cells in vitro and are expressed by endothelium in allergic cutaneous inflammation in vivo. J Immunol (1991) 2.57

The C terminus of human immunodeficiency virus type 1 matrix protein is involved in early steps of the virus life cycle. J Virol (1992) 2.51

Clinical characteristics and natural history of patients with acute myocardial infarction sent home from the emergency room. Am J Cardiol (1987) 2.50

Antibodies to cell membrane antigens associated with human T-cell leukemia virus in patients with AIDS. Science (1983) 2.48

Serological evidence for virus related to simian T-lymphotropic retrovirus III in residents of west Africa. Lancet (1986) 2.48

Enhanced expression of cyclo-oxygenase isoenzyme 2 (COX-2) in asthmatic airways and its cellular distribution in aspirin-sensitive asthma. Thorax (1997) 2.46

A computer protocol to predict myocardial infarction in emergency department patients with chest pain. N Engl J Med (1988) 2.46

Patient and house officer attitudes on physician attire and etiquette. JAMA (1987) 2.44

Association between virus-specific T-cell responses and plasma viral load in human immunodeficiency virus type 1 subtype C infection. J Virol (2003) 2.40

Prediction of the need for intensive care in patients who come to the emergency departments with acute chest pain. N Engl J Med (1996) 2.39

Synthesis and anti-inflammatory effect of chalcones and related compounds. Pharm Res (1998) 2.36

A naturally immunogenic virion-associated protein specific for HIV-2 and SIV. Nature (1988) 2.33

Antiserum to a synthetic peptide recognizes the HTLV-III envelope glycoprotein. Science (1986) 2.33

Leaving gatekeeping behind--effects of opening access to specialists for adults in a health maintenance organization. N Engl J Med (2001) 2.29

Covalent structure of human haptoglobin: a serine protease homolog. Proc Natl Acad Sci U S A (1980) 2.21

Mutational analysis of the leucine zipper-like motif of the human immunodeficiency virus type 1 envelope transmembrane glycoprotein. J Virol (1993) 2.21

Human immunodeficiency virus type 1 has an additional coding sequence in the central region of the genome. Proc Natl Acad Sci U S A (1988) 2.20

The vpx gene of simian immunodeficiency virus facilitates efficient viral replication in fresh lymphocytes and macrophage. J Virol (1991) 2.18

Recombinant tissue-type plasminogen activator versus urokinase in peripheral arterial and graft occlusions: a randomized trial. Radiology (1990) 2.14

Bacillary angiomatosis and bacillary splenitis in immunocompetent adults. Ann Intern Med (1993) 2.14

Hirayama disease: MR diagnosis. AJNR Am J Neuroradiol (1998) 2.14

Arterial blood gas analysis in the assessment of suspected acute pulmonary embolism. Chest (1996) 2.14

Direct peroral cholangioscopy using an ultraslim upper endoscope for management of residual stones after mechanical lithotripsy for retained common bile duct stones. Endoscopy (2012) 2.12

The relationship of postoperative delirium with psychoactive medications. JAMA (1994) 2.09

Clinical uses of low-molecular-weight heparins. Chest (1999) 2.05

Supraventricular arrhythmia in patients having noncardiac surgery: clinical correlates and effect on length of stay. Ann Intern Med (1998) 2.04

Identification of a new type of mammalian peroxiredoxin that forms an intramolecular disulfide as a reaction intermediate. J Biol Chem (2000) 2.04

Long-term cost-effectiveness of various initial monotherapies for mild to moderate hypertension. JAMA (1990) 2.01

Regional right ventricular dysfunction detected by echocardiography in acute pulmonary embolism. Am J Cardiol (1996) 2.01

Breaking the speed limits of phase-change memory. Science (2012) 2.01

Right heart catheterization and cardiac complications in patients undergoing noncardiac surgery: an observational study. JAMA (2001) 1.99

Leukotriene E4 and granulocytic infiltration into asthmatic airways. Lancet (1993) 1.98

Critical pathways intervention to reduce length of hospital stay. Am J Med (2001) 1.92

The association of intraoperative factors with the development of postoperative delirium. Am J Med (1998) 1.92

Cost-effectiveness of systematic depression treatment for high utilizers of general medical care. Arch Gen Psychiatry (2001) 1.92

Increased expression of the monocyte chemoattractant protein-1 in bronchial tissue from asthmatic subjects. Am J Respir Cell Mol Biol (1994) 1.92

New human T-lymphotropic retrovirus related to simian T-lymphotropic virus type III (STLV-IIIAGM). Science (1986) 1.91

Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design? J Virol (2002) 1.91

Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment. Brain Res Brain Res Rev (2001) 1.90

Human T-cell leukemia virus-associated membrane antigens: identity of the major antigens recognized after virus infection. Proc Natl Acad Sci U S A (1984) 1.88

Impact of age on perioperative complications and length of stay in patients undergoing noncardiac surgery. Ann Intern Med (2001) 1.88

The impact of an inpatient physician program on quality, utilization, and satisfaction. Am J Manag Care (2000) 1.87

Necrobacillosis: a forgotten disease. Br Med J (Clin Res Ed) (1984) 1.87

Acute chest pain in the emergency room. Identification and examination of low-risk patients. Arch Intern Med (1985) 1.86

A critical pathway for management of patients with acute chest pain who are at low risk for myocardial ischemia: recommendations and potential impact. Ann Intern Med (1997) 1.85

Complement receptor enhancement and chemotaxis of human neutrophils and eosinophils by leukotrienes and other lipoxygenase products. Clin Exp Immunol (1982) 1.84

Sensitivity of routine clinical criteria for diagnosing myocardial infarction within 24 hours of hospitalization. Ann Intern Med (1987) 1.81

Controversies surrounding long-term anticoagulation of very elderly patients in atrial fibrillation. Chest (1998) 1.81

Prevalence of deep venous thrombosis among patients in medical intensive care. JAMA (1995) 1.78

Prospective study of exogenous hormones and risk of pulmonary embolism in women. Lancet (1996) 1.78

Identification and partial characterization of an exercise-induced neutrophil chemotactic factor in bronchial asthma. J Clin Invest (1982) 1.77

Magnitude and frequency of cytotoxic T-lymphocyte responses: identification of immunodominant regions of human immunodeficiency virus type 1 subtype C. J Virol (2002) 1.77

Comparison of three-factor and four-factor prothrombin complex concentrates regarding reversal of the anticoagulant effects of rivaroxaban in healthy volunteers. J Thromb Haemost (2014) 1.74

Anticoagulation in dilated cardiomyopathy. J Am Coll Cardiol (1998) 1.69

Cardiac troponin I as a predictor of major cardiac events in emergency department patients with acute chest pain. J Am Coll Cardiol (1998) 1.68

Differential effects of extracellular matrix proteins on human airway smooth muscle cell proliferation and phenotype. Am J Respir Cell Mol Biol (2000) 1.68

Evaluation of screening criteria for adverse events in medical patients. Med Care (1995) 1.65

Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils. J Clin Invest (1984) 1.65

Evaluating decision aids: the next painful step. J Gen Intern Med (1991) 1.64

Utilization of venous thromboembolism prophylaxis in the medical intensive care unit. Chest (1994) 1.64

Emergency department triage strategies for acute chest pain using creatine kinase-MB and troponin I assays: a cost-effectiveness analysis. Ann Intern Med (1999) 1.63

D-dimer, factor VIII coagulant activity, low-intensity warfarin and the risk of recurrent venous thromboembolism. J Thromb Haemost (2006) 1.62

Hepatitis B virus X protein interferes with cellular DNA repair. J Virol (1998) 1.62

Nonrandom distribution of gp120 N-linked glycosylation sites important for infectivity of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A (1992) 1.61

Nonoperative management of posterior tibial tendon dysfunction. Foot Ankle Int (1996) 1.61